SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-239150
Filing Date
2020-09-03
Accepted
2020-09-03 17:21:38
Documents
16
Period of Report
2020-08-31
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d78642d8k.htm   iXBRL 8-K 28430
2 EX-1.1 d78642dex11.htm EX-1.1 222843
3 EX-5.1 d78642dex51.htm EX-5.1 12392
7 GRAPHIC g78642dsp53a.jpg GRAPHIC 3949
8 GRAPHIC g78642dsp54.jpg GRAPHIC 2539
  Complete submission text file 0001193125-20-239150.txt   462636

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA zsan-20200831.xsd EX-101.SCH 3080
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE zsan-20200831_lab.xml EX-101.LAB 18121
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zsan-20200831_pre.xml EX-101.PRE 11411
9 EXTRACTED XBRL INSTANCE DOCUMENT d78642d8k_htm.xml XML 3386
Mailing Address 34790 ARDENTECH COURT FREMONT CA 94555
Business Address 34790 ARDENTECH COURT FREMONT CA 94555 510-745-1200
Zosano Pharma Corp (Filer) CIK: 0001587221 (see all company filings)

IRS No.: 454488360 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36570 | Film No.: 201160012
SIC: 2834 Pharmaceutical Preparations